Amgen files Xgeva in US for prostate cancer prevention
29 June 2011
Nancy Faigen
Please Login to read the full article.
29 June 2011
Nancy Faigen
nancy.faigen@informausa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- US FDA rejects Amgen's Xgeva in prostate cancer; more data needed
- With questions raised on prostate cancer benefit, Amgen's Xgeva may face tough ODAC
- Amgen fails to convince ODAC of Xgeva's benefit in prostate cancer
- Amgen's Prolia gains FDA OK to strengthen bones in breast, prostate cancer
ANALYSIS
Other Informa Analysis
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
Today
Le Plaza Hotel, Brussels, Belgium
Today
Diplomat Hotel, Prague, Czech Republic
Today
Business Design Centre, London
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
